alnylam pharmaceuticals inc
Thomas H. Tuschl Ph.D.
Member of Scientific Advisory Board, Alnylam Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 25 board members in 2 different organizations across 2 different industries.|
See Board Relationships
Dr. Thomas H. Tuschl Ph.D. is an Associate Professor at Rockefeller University. Dr. Tuschl serves as a Member of the Scientific Advisory Board at Alnylam Pharmaceuticals Inc., and Regulus Therapeutics Inc.
300 Third StreetPhone: 617-551-8200
Cambridge, Massachusetts 02142
Board Members Memberships*There is no Board Members Memberships data available.
Education*There is no Education data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Stanley T. Crooke M.D., Ph.D.||Founder, Executive Chairman, Chief Executive Officer, President and Member of Non-Management Stock Option Committee|
Isis Pharmaceuticals, Inc.
|Christopher R. Anzalone Ph.D.||Chief Executive Officer, President, Director, Chief Executive Officer of Calando, Chief Executive Officer of Tego, Chief Executive Officer of Nantope, Chief Executive Officer of Leonardo and Chief Executive Officer of Ablaris Therapeutics|
Arrowhead Research Corp.
|Christopher Nishan Garabedian||Chief Executive Officer, President and Director|
Sarepta Therapeutics, Inc.
|Mark J. Ahn Ph.D.||Chief Executive Officer, President, Director and Member of Strategy Committee|
Galena Biopharma, Inc.
|Kleanthis G. Xanthopoulos Ph.D.||Chief Executive Officer, President, Principal Financial & Accounting Officer and Director|
Regulus Therapeutics Inc.
|$515.5K||Compensation as of Fiscal Year 2012.|
Post a JobJobs
- Pittsburgh, PA | Carnegie Museums of PittsburghPosted: Dec 09
- New York, NY | JPMorgan ChasePosted: Dec 06
- Alexandria, VA |Posted: Dec 06
- Detroit, MI | Wayne State UniversityPosted: Nov 26